Cervical Cancer
Filter
18
Featured
Language
Document type
Guidelines
7
Fact sheets
3
Studies & Reports
2
Training Material
1
Situation Updates
1
Infographics
1
Online Courses
1
Videos
1
Strategic & Response Plan
1
Countries / Regions
Middle East and North Africa
1
South–East Asia Region
1
South Africa
1
India
1
Authors & Publishers
World Health Organization WHO
8
World Health Organisation (WHO)
4
and S. Mauder
1
Dept. of Health, Republic of South Africa
1
Eastern Mediterranean Region
1
ecancer Education
1
Henke, A.
1
Lakhbir Dhaliwal, Vanita Suri, Reshmi Bagga et al.
1
Medica Aid Films
1
National Cancer Crid, India
1
The MEDBOX Team
1
UNAIDS
1
World Health Organization
1
Publication Years
Category
Cervical Cancer
18
Cancer
7
Gynaecology & Obstetrics
4
Reproductive Health
3
Policies
2
Women & Child Health
2
Clinical Training
1
x MEDBOX Issue Brief & Annual Reports x
1
Community Health
1
Breast Cancer
1
Maternal & Child Health
1
Guidelines
1
Capacity Building
1
Maternal Health
1
Toolboxes
Cancer
3
Videos
1
Handbooks & Manuals
1
Community Health Workers CHW
1
Women & Maternal Health
1
Women
1
Cervical cancer is the second most common cancer among women worldwide and causes a significant number of deaths in the South-East Asia Region. Nearly 200 000 new cases of cervical cancer occurred in SEA Region Member States in 2008, giving an incidence of almost 25 per 100... more
Cervical cancer, along with maternal deaths, has been identified as a national priority in South Africa as well as other Sub-Saharan African countries. Cervical cancer is the second most common cancer among women in South Africa, after breast cancer. Due to limited access to prevention, early dia... more
A new e-learning course has just been released, aimed at healthcare professionals working with patients in India exploring HPV screening and vaccination, assessment and diagnosis of cervical cancer, and palliative care for patients with advanced cervical cancer. The course was developed by ecancer i... more
It is estimated that more than 311 000 women die of cervical cancer each year. Of these deaths, 91% occur in low- and middle-income countries. Demographic changes and a lack of action mean that the number of deaths per year is projected to reach 460 000 by 2040.
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the... more
2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendati... more
Globally, 311,000 women die of cervical cancer every year, 85 percent of them in resource limited regions of the world. To address this grave threat to women, the WHO made a call to action in 2018, resulting in accelerated plans to improve cervical cancer control under the elimination threshold w... more
This film explains the importance of screening, early detection and treatment of cervical cancer. This film is for use in skilled health worker training. Available in English, French, Somali and Swahili

Women Cancer

Henke, A.; and S. Mauder The MEDBOX Team (2021) CC
MEDBOX Issue Brief No.17, 21 November 2021 Women's cancers have a significant impact on women's health worldwide. According to the World Health Organisation, nearly three million women are diagnosed with breast or cervical cancer every year. In this Issue Brief you will find more information.
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV and cervical cancer are inextricably linked. Women living with HIV are six times more likely to develop cervical cancer, which is o... more
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ... more
Self-care interventions are evidence-based, quality drugs, devices, diagnostics and/or digital products which can be provided fully or partially outside of formal health services and can be used with or without the direct supervision of health care personnel. Where HPV tests are available as part o... more
Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and 311,000 deaths occurring annually.T he highest incidence rates are in Southern Africa, Eastern Africa, SubSaharan Africa, Western Africa, Melanesia, and Middle Africa . It also ranks as the leadin... more